References

Acute respiratory distress syndrome advances in diagnosis and treatment

10.1001/jama.2017.21907 · 2018 · External reference

Non-invasive ventilatory support and high-flow nasal oxygen as first-line treatment of acute hypoxemic respiratory failure and ARDS

10.1007/s00134-021-06459-2 · 2021 · External reference

Association of noninvasive oxygenation strategies with all-cause mortality in adults with acute hypoxemic respiratory failure: a systematic review and meta-analysis

10.1001/jama.2020.9524 · 2020 · External reference

Hypoxemic patients with bilateral infiltrates treated with high-flow nasal cannula present a similar pattern of biomarkers of inflammation and injury to acute respiratory distress syndrome patients

10.1097/ccm.0000000000002647 · 2017 · External reference

A new global definition of acute respiratory distress syndrome

2024 · External reference

Subphenotypes in patients with acute respiratory distress syndrome treated with high-flow oxygen

10.1186/s13054-023-04687-0 · 2023 · External reference

High-flow nasal oxygen for severe hypoxemia oxygenation response and outcome in patients with COVID-19

10.1164/rccm.202109-2163oc · 2022 · External reference

Use of high-flow nasal cannula and noninvasive ventilation in patients with COVID-19: a multicenter observational study

10.1016/j.ajem.2020.07.071 · 2021 · External reference

Comparison of COVID-19 induced respiratory failure and typical ARDS: similarities and differences

2022 · External reference

Markers of endothelial and epithelial pulmonary injury in mechanically ventilated COVID-19 ICU patients

10.1186/s13054-021-03499-4 · 2021 · External reference

COVID-19 versus Non-COVID-19 acute respiratory distress syndrome comparison of demographics, physiologic parameters, inflammatory biomarkers, and clinical outcomes

10.1513/annalsats.202008-1026oc · 2021 · External reference

Acute respiratory distress syndrome: the Berlin definition

2012 · External reference

APACHE II: a severity of disease classification system

10.1097/00003246-198510000-00009 · 1985 · External reference

Unresolved reference

1996 · External reference

Distinct molecular phenotypes of direct vs indirect ARDS in single-center and multicenter studies

10.1378/chest.14-2454 · 2015 · External reference

Biomarkers of lung epithelial injury and inflammation distinguish severe sepsis patients with acute respiratory distress syndrome

10.1186/cc13080 · 2013 · External reference

Plasma angiopoietin-2 in clinical acute lung injury: prognostic and pathogenetic significance

10.1097/ccm.0b013e3182451c87 · 2012 · External reference

Elevated plasma and alveolar levels of soluble receptor for advanced glycation endproducts are associated with severity of lung dysfunction in ARDS patients

10.1620/tjem.222.105 · 2010 · External reference

Plasma surfactant protein levels and clinical outcomes in patients with acute lung injury

10.1136/thorax.58.11.983 · 2003 · External reference

Plasma angiopoietin-2 predicts the onset of acute lung injury in critically ill patients

10.1164/rccm.201208-1460oc · 2013 · External reference

Unresolved reference

External reference

Circulating angiopoietin 2 correlates with mortality in a surgical population with acute lung injury/adult respiratory distress syndrome

10.1097/shk.0b013e31815dd92f · 2008 · External reference

Timing of intubation and clinical outcomes in adults with acute respiratory distress syndrome

10.1097/ccm.0000000000001359 · 2016 · External reference

Use of high-flow nasal cannula oxygen therapy in subjects with ARDS: a 1-year observational study

10.4187/respcare.03423 · 2015 · External reference

Serum surfactant protein D in COVID-19 is elevated and correlated with disease severity

10.1186/s12879-021-06447-3 · 2021 · External reference

Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis

10.1172/jci.insight.140289 · 2020 · External reference